Search Results - "Ng, Theodore W.K"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease by Ooi, Esther M.M., Chan, Doris T., Watts, Gerald F., Chan, Dick C., Ng, Theodore W.K., Dogra, Gursharan K., Irish, Ashley B., Barrett, P. Hugh R.

    Published in Journal of lipid research (01-04-2011)
    “…Moderate chronic kidney disease (CKD) (defined by an estimated glomerular filtration rate of 30–60 ml/min) is associated with mild hypertriglyceridemia related…”
    Get full text
    Journal Article
  2. 2

    Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update by Ooi, Esther M M, Watts, Gerald F, Ng, Theodore W K, Barrett, P Hugh R

    Published in Nutrients (02-06-2015)
    “…Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Dietary fatty-acid composition regulates lipids and lipoprotein metabolism and may confer…”
    Get full text
    Journal Article Book Review
  3. 3

    Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels by Ng, Theodore W.K, Watts, Gerald F, Barrett, P. Hugh R, Rye, Kerry-Anne, Chan, Dick C

    Published in Diabetes care (01-11-2007)
    “…OBJECTIVE:--The purpose of this study was to examine the effect of weight loss on LDL and HDL kinetics and plasma retinol-binding protein-4 (RBP-4) and…”
    Get full text
    Journal Article
  4. 4

    Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome by Ooi, Esther M.M., Ng, Theodore W.K., Watts, Gerald F., Chan, Dick C., Barrett, P. Hugh R.

    Published in Journal of lipid research (01-11-2012)
    “…We examined the effects of fenofibrate and atorvastatin on very low density lipoprotein (VLDL) apolipoprotein (apo)E metabolism in the metabolic syndrome…”
    Get full text
    Journal Article
  5. 5

    Adipocytokines and VLDL metabolism : Independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? by NG, Theodore W. K, WATTS, Gerald F, FARVID, Maryam S, CHAN, Dick C, BARRETT, P. Hugh R

    Published in Diabetes (New York, N.Y.) (01-03-2005)
    “…We investigated the relationship of plasma adipocytokine concentrations with VLDL apolipoprotein B (apoB)-100 kinetics in men. Plasma adiponectin, leptin,…”
    Get full text
    Journal Article
  6. 6

    Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism by Chan, Dick C, Watts, Gerald F, Ng, Theodore W.K, Uchida, Yoshiaki, Sakai, Naohiko, Yamashita, Shizuya, Barrett, P. Hugh R

    Published in Clinical chemistry (Baltimore, Md.) (01-03-2005)
    “…Adipocytokines are bioactive peptides that may play an important role in the regulation of glucose and lipid metabolism. In this study, we investigated the…”
    Get full text
    Journal Article
  7. 7

    Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes by Ooi, Esther M.M, Ng, Theodore W.K, Chan, Dick C, Watts, Gerald F

    Published in Diabetes research and clinical practice (01-09-2009)
    “…Abstract Aims We investigated the associations between indices of cholesterol metabolism and features of the metabolic syndrome (MS) in the presence and…”
    Get full text
    Journal Article
  8. 8

    Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome by Ng, Theodore W.K., Watts, Gerald F., Barrett, P. Hugh R., Rye, Kerry-Anne, Chan, Dick C.

    Published in Diabetes care (01-11-2007)
    “…Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome Associations with changes in plasma retinol-binding protein-4 and adiponectin levels…”
    Get full text
    Journal Article
  9. 9

    Adipocytokines and VLDL Metabolism by Ng, Theodore W.K., Watts, Gerald F., Farvid, Maryam S., Chan, Dick C., Barrett, P. Hugh R.

    Published in Diabetes (New York, N.Y.) (01-03-2005)
    “…Adipocytokines and VLDL Metabolism Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100…”
    Get full text
    Journal Article
  10. 10

    Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome by Ng, Theodore W. K, Ooi, Esther M. M, Watts, Gerald F, Chan, Dick C, Weir, Jacquelyn M, Meikle, Peter J, Barrett, P. Hugh R

    “…Context: Statins are effective cholesterol-lowering agents that reduce cardiovascular disease risk but also have pleiotropic effects that may extend to other…”
    Get full text
    Journal Article
  11. 11

    Dietary fatty acids and lipoprotein metabolism: new insights and updates by Ooi, Esther M.M., Ng, Theodore W.K., Watts, Gerald F., Barrett, P. Hugh R.

    Published in Current opinion in lipidology (01-06-2013)
    “…Dyslipidemia is a powerful risk factor for cardiovascular disease (CVD). Dietary fatty acid composition regulates lipids and lipoprotein metabolism and may…”
    Get full text
    Journal Article
  12. 12

    Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment by Ng, Theodore W. K, Ooi, Esther M. M, Watts, Gerald F, Chan, Dick C, Meikle, Peter J, Barrett, P. Hugh R

    “…Introduction: The objective of the study was to examine post hoc associations between plasma sphingolipids and lipoprotein kinetics in men with the metabolic…”
    Get full text
    Journal Article
  13. 13

    Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis by Chan, Dick C, Ng, Theodore W K, Watts, Gerald F

    Published in Annals of medicine (Helsinki) (01-06-2012)
    “…Reduced HDL cholesterol, commonly found in subjects with obesity and type 2 diabetes, is associated with increased risk of cardiovascular disease (CVD)…”
    Get more information
    Journal Article
  14. 14

    Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men by Wong, Annette T Y, Chan, Dick C, Ooi, Esther M M, Ng, Theodore W K, Watts, Gerald F, Barrett, P Hugh R

    Published in Clinical science (1979) (01-07-2013)
    “…Dysregulated VLDL-TAG (very-low-density lipoprotein triacylglycerol) metabolism in obesity may account for hypertriacylglycerolaemia and increased…”
    Get more information
    Journal Article
  15. 15

    Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome by Ng, Theodore W K, Chan, Dick C, Barrett, P Hugh R, Watts, Gerald F

    Published in Clinical science (1979) (01-01-2010)
    “…Reduced HDL (high-density lipoprotein) concentration in the MetS (metabolic syndrome) is associated with increased risk of cardiovascular disease and is…”
    Get more information
    Journal Article
  16. 16

    Genetic determinants of apolipoprotein B-100 kinetics by Ng, Theodore W K, Ooi, Esther M M, Watts, Gerald F, Chan, Dick C, Barrett, P Hugh R

    Published in Current opinion in lipidology (01-04-2010)
    “…We review stable isotope tracer studies of apolipoprotein B-100 (apoB) kinetics concerning genetic polymorphisms and mutations that affect human lipoprotein…”
    Get full text
    Journal Article
  17. 17

    Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men by Chan, Dick C., Watts, Gerald F., Ng, Theodore W.K., Uchida, Yoshiaki, Sakai, Naohiko, Yamashita, Shizuya, Barrett, P. Hugh R.

    Published in Clinical biochemistry (01-09-2005)
    “…We examined the association of plasma apolipoprotein (apoB) B-48, remnant-like particle (RLP)-cholesterol and non-HDL cholesterol concentrations with apoB-100…”
    Get full text
    Journal Article